Saturated fatty acid (SFA) exposure causes nonalcoholic steatohepatitis (NASH). Inflammation is the leading cause of pathologies of nonalcoholic fatty liver disease, containing NASH. However, it is uncertain how SFA induces inflammation. Increasing ev...
Saturated fatty acid (SFA) exposure causes nonalcoholic steatohepatitis (NASH). Inflammation is the leading cause of pathologies of nonalcoholic fatty liver disease, containing NASH. However, it is uncertain how SFA induces inflammation. Increasing evidence has demonstrated that caspase-1 activation and pyroptosis contribute to the development of NASH. In addition, we found that SIRT1 activity was associated with palmitic acid-induced elevation of NLRP3 inflammasome, attenuating caspase-1 expression, and reducing LDH release, and apoptosis. Interestingly, ROSA26-Cre; SIRT1fl/fl (exon 4) conditional knockout contributed to liver damage due to NLRP3 inflammasome, caspase-1 expression, LDH release, and pyroptotic cell death. The human liver cancer cell line HepG2 cells were exposed to palmitic acid (PA). Cells also induced NLRP3 inflammasome or GSDMD/pyroptosis during PA treatment for 24 hours. Thus, ROSA26-Cre; SIRT1fl/fl (exon 4) conditional knockout mouse displayed hyperactivated NLRP3 inflammasome, which resulted in hyperactivation of inflammasomes and increased mortality in NASH models. These findings define a unique regulatory mechanism of NLRP3 inflammasome activation from GSDMD/pyroptosis.